Humans, equine, canine, bovine, feline and other animals, and in particular, mammals, suffering from diseases mediated by proteases, can be treated by administering to the patient or animal an effective amount of NAC or a pharmaceutically acceptable derivative or salt thereof in a pharmaceutically acceptable carrier or diluent.